Is pregnancy wise after 12-year chemotherapy of chronic myeloid leukemia woman?

Abstract

Diagnosis of leukemia during pregnancy is a dramatic event that poses challenges to the pregnant woman, the family, and physicians. Chronic myeloid leukemia (CML) comprises up to 10% of pregnancy-associated leukemia. There is no specific guideline for CML management in pregnant women. This study reported a case of successful pregnancy after 12 years of chemotherapy including tyrosine kinase inhibitor for CML. Pregnancy after 12 years of continuous chemotherapy is rare, which also led a challenge for medical oncologists and patient as well. This study described the assessment of the risk balance and benefit and management of such a patient.

Keywords

Chronic myeloid leukemia / imatinib / pregnancy / tyrosine kinase inhibitor

References

[1] Rowley JD.Letter: A new consistent chromosomal abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and Giemsa staining..Nature1973;243:290-3

[2] Hensley ML.Imatinib treatment: specific issues related to safety, fertility, and pregnancy..Semin Hematol2003;40:21-5

[3] Slade R.Pregnancy and maternal malignant hematological disorders..In: Turner TL, editor. Perinatal Hematological Problems.1991;ChichesterJohn Wiley and Sons Ltd23-38

[4] Rothman LA,Astarloa J.Placental and fetal involvement by maternal malignancy: a report of rectal carcinoma and review of the literature..Am J Obstet Gynecol1973;116:1023-34

[5] Lichtman M.Acute myelogenous leukemia..Williams Hematology. 6th ed.2001;New YorkMcGraw-Hill1047-84

[6] Doll DC,Yarbro JW.Management of cancer during pregnancy..Arch Intern Med1988;148:2058-64

[7] Buekers TE.Chemotherapy in pregnancy..Obstet Gynecol Clin North Am1998;25:323-9

[8] Zuazu J,Sierra J,Coma A,Batlle J.Pregnancy outcome in hematologic malignancies..Cancer1991;67:703-9

[9] Ault P,O'Brien S,Beran M,Koller C,Keating M,Cortes J.Pregnancy among patients with chronic myeloid leukemia treated with imatinib..J Clin Oncol2006;24:1204-8

[10] Pye SM,Ault P,Kantarjian H,Rosti G.The effects of imatinib on pregnancy outcome..Blood2008;111:5505-8 PMCID:PMC4916938

[11] Cortes J,Ault P,Jabbour E,Debreczeni K,Liu D.Pregnancy outcomes among patients with chronic myeloid leukemia treated with dasatinib..Blood2008;112:abstract 3230

[12] Cole S,Ault P.Successful completion of pregnancy in a patient with chronic myeloid leukemia without active intervention: a case report and review of the literature..Clin Lymphoma Myeloma2009;9:324-7

[13] Conchon M,Serpa M,Nardinelli L,Dorliac PE.Successful Pregnancy and Delivery in a Patient with Chronic Myeloid Leukemia while on Dasatinib Therapy..Adv Hematol2010;2010:136252 PMCID:PMC2833316

[14] Tasigna (nilotinib) [package Insert]. East Hanover: Novartis Pharmaceuticals Corporation; 2007. Available from: https://www.pharma.us.novartis.com/product/pi/pdf/tasigna.pdf. [Last accessed on 2015 Sep 30]

[15] Conchon M,Bendit I,Serpa M.Two successful pregnancies in a woman with chronic myeloid leukemia exposed to nilotinib during the first trimester of her second pregnancy: case study..J Hematol Oncol2009;2:42 PMCID:PMC2763010

[16] Hochhaus A.Educational session: managing chronic myeloid leukemia as a chronic disease..Hematology Am Soc Hematol Educ Program2011;2011:128-35

[17] Kuwabara A,Ibrahim A,Apperley J,Reid A,Rezvani K,Marin D.Poor outcome after reintroduction of imatinib in patients with chronic myeloid leukemia who interrupt therapy on account of pregnancy without having achieved an optimal response..Blood2010;116:1014-6 PMCID:PMC2924222